Clinical Trial Update: Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Ofatumumab versus Rituximab salvage chemoimmunotherapy followed by autologous stem cell transplant in relapsed or refractory diffuse lar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Ofatumumab (ofatumumab)
• Rituximab (rituximab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Large-Cell, Diffuse | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16